OM:EKTA BMedical Equipment
Elekta (OM:EKTA B) Valuation Check After Wider Losses And Brighter Sales And Margin Guidance
Elekta (OM:EKTA B) has come into focus after reporting larger net losses for the fourth quarter and full year to April 30, 2026, while simultaneously issuing guidance for higher constant currency net sales and an improved EBIT margin in 2026/2027.
See our latest analysis for Elekta.
Elekta's stock has been under pressure in recent months, with a 90 day share price return down 10.81%. However, the 1 year total shareholder return of 16.14% points to recovering sentiment despite the wider multi...